The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis

被引:22
|
作者
Toya, Yosuke [1 ]
Chiba, Toshimi [1 ]
Mizutani, Tomomi [1 ]
Sato, Kunihiko [1 ]
Kasugai, Satoshi [1 ]
Matsuda, Nozomi [1 ]
Orikasa, Shunsuke [1 ]
Shibata, Sho [1 ]
Abiko, Yukito [1 ]
Akasaka, Risaburo [1 ]
Yokoyama, Naoki [1 ]
Oana, Shuhei [1 ]
Hirota, Shigeru [1 ]
Endo, Masaki [1 ]
Suzuki, Kazuyuki [1 ]
机构
[1] Iwate Med Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Morioka, Iwate 0208505, Japan
关键词
Ulcerative colitis; Granulocyte and monocyte adsorptive apheresis; GMA; Cytokine levels; Interleukin-10; INFLAMMATORY-BOWEL-DISEASE; REFRACTORY CROHNS-DISEASE; POLYMORPHONUCLEAR NEUTROPHILS; SELECTIVE LEUKOCYTAPHERESIS; INTESTINAL INFLAMMATION; INDUCIBLE PROTEIN-10; T-CELLS; ADACOLUMN; EFFICACY; THERAPY;
D O I
10.1016/j.cyto.2013.01.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Granulocyte and monocyte adsorptive apheresis (GMA) with an Adacolumn has been reported to be effective as induction therapy in ulcerative colitis (UC). However, the effects of GMA on serial changes in cytokine levels have not been well characterized. We therefore, investigated cytokine levels in UC patients before and after treatment with GMA. A total of 16 patients with active UC, 10 men, and six women, mean age, 42.6 years were included. Fourteen patients had total colitis and two patients had left-sided colitis. The study included nine patients with a chronic intermittent course, six with a chronic continuous course and one with a single episode. The duration of each GMA session was 60 min at a flow rate of 30 mL/min as per study protocol. Serum levels of 17 cytokines were determined simultaneously using a Bio-Plex suspension array system before and after treatment with GMA. Serum interleukin (IL)-10 and macrophage inflammatory protein-1 beta levels were increased significantly in UC patients after GMA treatment compared to pre-treatment levels (P < 0.05). In particular, GMA treatment caused a significant increase in serum IL-10 levels compared to pre-treatment in patients with total colitis or with a chronic intermittent UC course. In conclusion, this investigation showed that GMA was associated with a marked increase in serum level of the anti-inflammatory cytokine, IL-10. The rise in circulating IL-10 is interesting, and potentially a significant factor in the efficacy of GMA in patients with inflammatory bowel diseases. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:146 / 150
页数:5
相关论文
共 50 条
  • [41] Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study
    Yamamoto, T
    Umegae, S
    Kitagawa, T
    Yasuda, Y
    Yamada, Y
    Takahashi, D
    Mukumoto, M
    Nishimura, N
    Yasue, K
    Matsumoto, K
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (07) : 783 - 792
  • [42] Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
    Yoko Yokoyama
    Mikio Kawai
    Ken Fukunaga
    Koji Kamikozuru
    Kazuko Nagase
    Koji Nogami
    Tomoaki Kono
    Yoshio Ohda
    Masaki Iimuro
    Nobuyuki Hida
    Shiro Nakamura
    Hiroto Miwa
    Takayuki Matsumoto
    BMC Gastroenterology, 13
  • [43] A retrospective study to investigate the efficacy and safety of granulocyte and monocyte adsorptive apheresis in patients with primary sclerosing cholangitis with ulcerative colitis
    Ito, Ayumi
    Murasugi, Shun
    Yonezawa, Maria
    Omori, Teppei
    Nakamura, Shinichi
    Tokushige, Katsutoshi
    JOURNAL OF CLINICAL APHERESIS, 2024, 39 (01)
  • [44] The utility as a biomarker of faecal calprotectin for predicting the clinical outcome of granulocyte and monocyte adsorptive apheresis treatment in patients with ulcerative colitis
    Ueno, N.
    Murakami, Y.
    Iwama, T.
    Sasaki, T.
    Kunogi, T.
    Takahashi, K.
    Tanaka, K.
    Ando, K.
    Kashima, S.
    Inaba, Y.
    Moriichi, K.
    Tanabe, H.
    Taruishi, M.
    Fujiya, M.
    Okumura, T.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S423 - S424
  • [45] Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA
    Yokoyama, Yoko
    Kawai, Mikio
    Fukunaga, Ken
    Kamikozuru, Koji
    Nagase, Kazuko
    Nogami, Koji
    Kono, Tomoaki
    Ohda, Yoshio
    Iimuro, Masaki
    Hida, Nobuyuki
    Nakamura, Shiro
    Miwa, Hiroto
    Matsumoto, Takayuki
    BMC GASTROENTEROLOGY, 2013, 13
  • [46] Safety and efficacy of daily granulocyte and monocyte adsorptive apheresis in 50 consecutive patients with active ulcerative colitis: a prospective study
    Yamamoto, T.
    Shimoyama, T.
    Umegae, S.
    Matsumoto, K.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S427 - S428
  • [47] Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy
    Sagawa, T.
    Kakizaki, S.
    Tomizawa, T.
    Nakayama, T.
    Tanaka, H.
    Tojima, H.
    Sato, K.
    Kusano, M.
    Okamura, S.
    Yamada, M.
    COLORECTAL DISEASE, 2016, 18 (07) : 696 - 702
  • [48] Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study
    Sakata, Yasuhisa
    Iwakiri, Ryuichi
    Amemori, Sadahiro
    Yamaguchi, Kanako
    Fujise, Takehiro
    Otani, Hibiki
    Shimoda, Ryo
    Tsunada, Seji
    Sakata, Hiroyuki
    Ikeda, Yuji
    Ando, Takashi
    Nakafusa, Yuji
    Fujimoto, Kazuma
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (07) : 629 - 633
  • [49] Granulocyte and monocyte adsorptive apheresis as a first-line treatment for steroid-naive patients with active ulcerative colitis
    Suzuki, Y
    Yoshimura, N
    Tokida, K
    Katsuno, T
    Saito, Y
    Saniabadi, A
    GASTROINTESTINAL ENDOSCOPY, 2003, 57 (05) : AB216 - AB216
  • [50] Potential role of granulocyte/monocyte adsorptive apheresis for ulcerative colitis with concomitant CMV infection: authors' reply
    Thanaraj, S.
    Hamlin, P. J.
    Ford, A. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2011, 33 (04) : 498 - 498